Found: 50
Select item for more details and to access through your institution.
Low‐dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E260, doi. 10.1002/ajh.25908
- By:
- Publication type:
- Article
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. E159, doi. 10.1002/ajh.25102
- By:
- Publication type:
- Article
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 797, doi. 10.1002/ajh.24774
- By:
- Publication type:
- Article
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 2, p. 119, doi. 10.1002/ajh.23593
- By:
- Publication type:
- Article
Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 12, p. 960, doi. 10.1002/ajh.21871
- By:
- Publication type:
- Article
Flow Cytometry Assessment of CD26<sup>+</sup> Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia.
- Published in:
- Cytometry. Part B, 2019, v. 96, n. 4, p. 294, doi. 10.1002/cyto.b.21764
- By:
- Publication type:
- Article
The multi‐tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real‐world data.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 3, doi. 10.1111/ejh.13408
- By:
- Publication type:
- Article
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.672287
- By:
- Publication type:
- Article
Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.631570
- By:
- Publication type:
- Article
Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00883
- By:
- Publication type:
- Article
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26<sup>+</sup> leukemia stem cells.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1194712
- By:
- Publication type:
- Article
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2044
- By:
- Publication type:
- Article
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0333-2
- By:
- Publication type:
- Article
Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection.
- Published in:
- 2002
- By:
- Publication type:
- case study
Late-onset neutropenia (LON) recur in a MS patient after the second cycle of ocrelizumab: a case report.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 6, p. 2802, doi. 10.1002/cam4.2147
- By:
- Publication type:
- Article
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 11, p. 1527, doi. 10.1080/0284186X.2021.1971292
- By:
- Publication type:
- Article
Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 1, p. 53, doi. 10.1111/j.1600-0609.2007.00861.x
- By:
- Publication type:
- Article
Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 1, p. 23, doi. 10.1034/j.1600-0609.2003.00087.x
- By:
- Publication type:
- Article
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yr.
- Published in:
- European Journal of Haematology, 2002, v. 69, n. 4, p. 200, doi. 10.1034/j.1600-0609.2002.02806.x
- By:
- Publication type:
- Article
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic‐phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 17, p. 2637, doi. 10.1002/cncr.34923
- By:
- Publication type:
- Article
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. 440, doi. 10.1111/bjh.18537
- By:
- Publication type:
- Article
Next‐generation sequencing improves BCR‐ABL1 mutation detection in Philadelphia chromosome‐positive acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 271, doi. 10.1111/bjh.17301
- By:
- Publication type:
- Article
Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 2, p. 267, doi. 10.1111/bjh.14553
- By:
- Publication type:
- Article
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review.
- Published in:
- 2021
- By:
- Publication type:
- case study
Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.832890
- By:
- Publication type:
- Article
Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.832890
- By:
- Publication type:
- Article
Imatinib in Very Elderly Patients with Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Study.
- Published in:
- Drugs & Aging, 2013, v. 30, n. 8, p. 629, doi. 10.1007/s40266-013-0088-6
- By:
- Publication type:
- Article
How log-normal is your country? An analysis of the statistical distribution of the exported volumes of products.
- Published in:
- European Physical Journal: Special Topics, 2016, v. 225, n. 10, p. 1985, doi. 10.1140/epjst/e2015-50320-7
- By:
- Publication type:
- Article
Haematological Drugs Affecting Lipid Metabolism and Vascular Health.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081935
- By:
- Publication type:
- Article
Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.804714
- By:
- Publication type:
- Article
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4623, doi. 10.3390/cancers15184623
- By:
- Publication type:
- Article
Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1311, doi. 10.3390/cancers13061311
- By:
- Publication type:
- Article
Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 401, doi. 10.1002/hon.2851
- By:
- Publication type:
- Article
Favorable outcome of chronic myeloid leukemia co‐expressing e13a2 and e14a2 transcripts, treated with nilotinib.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 607, doi. 10.1002/hon.2765
- By:
- Publication type:
- Article
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 2, p. 363, doi. 10.1002/hon.2020
- By:
- Publication type:
- Article
Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 1998, v. 102, n. 2, p. 444, doi. 10.1046/j.1365-2141.1998.00796.x
- By:
- Publication type:
- Article
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
- By:
- Publication type:
- Article
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1375, doi. 10.1007/s00277-023-05159-9
- By:
- Publication type:
- Article
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2005, doi. 10.1007/s00277-020-04392-w
- By:
- Publication type:
- Article
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy.
- Published in:
- 2019
- By:
- Publication type:
- letter
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 8, p. 1885, doi. 10.1007/s00277-019-03705-y
- By:
- Publication type:
- Article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 2, p. 179, doi. 10.1007/s00277-012-1591-2
- By:
- Publication type:
- Article
Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
- Published in:
- Annals of Hematology, 2006, v. 85, n. 6, p. 394, doi. 10.1007/s00277-005-0058-0
- By:
- Publication type:
- Article